Coccidiosis on poultry: what is it, causes, symptoms, prevention

Coccidiosis in poultry: a persistent threat to flock health and productivity

Coccidiosis, an insidious parasitic disease, remains one of the most significant challenges facing the global poultry industry. Caused by various species of the protozoan parasite Eimeria, this ubiquitous disease inflicts substantial economic losses annually, impacting everything from growth rates and feed efficiency to overall flock uniformity and mortality. Understanding the complexities of coccidiosis, its lifecycle, and the various strategies for its control is paramount for maintaining healthy and productive poultry operations.

The invisible enemy: understanding Eimeria and its impact

Eimeria species are protozoan parasites that primarily target the intestinal lining of poultry. Each Eimeria species has a predilection for a specific part of the intestine, leading to varied clinical manifestations. For instance, E. tenella is notorious for causing severe caecal coccidiosis, often characterized by bloody droppings and high mortality, while E. acervulina and E. maxima typically affect the upper and middle small intestine, respectively, leading to malabsorption and reduced performance.

The life cycle of Eimeria is direct and involves both asexual and sexual reproduction within the host’s intestinal cells. Birds become infected by ingesting infective oocysts (egg-like bodies) from contaminated litter, feed, or water. Once ingested, these oocysts release sporozoites that invade the intestinal cells, initiating a cycle of rapid multiplication. This cellular invasion and destruction lead to compromised gut integrity, inflammation (enteritis), and a cascade of negative effects on the bird’s health. The damaged intestinal lining struggles to absorb nutrients, leading to poor weight gain, reduced feed conversion, and increased susceptibility to secondary bacterial infections like necrotic enteritis, often caused by Clostridium perfringens.

The economic burden of coccidiosis

The financial impact of coccidiosis on the poultry industry is staggering, with global estimates of losses reaching billions of dollars annually. These losses stem from several key areas:

• Reduced performance: subclinical coccidiosis, often without overt clinical signs, can severely impair growth rates and feed conversion ratios (FCR). Birds expend energy fighting the infection rather than converting feed into muscle or eggs, leading to inefficient production.
• Mortality: severe clinical outbreaks, particularly those involving E. tenella or concurrent infections, can result in high mortality rates, directly impacting flock numbers and profitability.
• Treatment and prevention costs: the continuous need for prophylactic medications (anticoccidials) in feed or the implementation of vaccination programs adds significant operational costs.
• Secondary infections: the damaged gut lining due to coccidiosis creates an entry point for other pathogens, leading to additional disease outbreaks and the need for further veterinary intervention and medication.
• Reduced product quality: coccidiosis can affect carcass pigmentation in broilers and egg quality in layers, leading to a decrease in market value.

Navigating control strategies

Effective coccidiosis control demands a comprehensive and integrated approach, combining biosecurity, environmental management, and targeted interventions.

Biosecurity and environmental control

These are foundational to minimizing coccidia challenge. Eimeria oocysts are remarkably resistant and can survive in the environment for extended periods. Strict biosecurity measures, including controlled access to poultry houses, rigorous cleaning and disinfection between flocks, and effective pest control, are essential. Maintaining dry litter is critical, as moisture and warmth provide ideal conditions for oocyst sporulation and infectivity. Proper ventilation and appropriate stocking density also contribute to a less favorable environment for the parasites.

Anticoccidial medications

For decades, anticoccidial drugs administered in feed have been a cornerstone of prevention. These can be broadly categorized into ionophores (e.g., monensin, salinomycin, narasin) and chemical compounds (e.g., nicarbazin, robenidine). Ionophores work by disrupting ion balance within the parasite, allowing for a degree of “trickle infection” that can help build immunity over time. However, the widespread and often continuous use of these drugs has led to increasing concerns about drug resistance in Eimeria species, necessitating careful rotation and shuttle programs to maintain efficacy.

Vaccination

Live attenuated vaccines, containing weakened strains of various Eimeria species, are a powerful tool for inducing strong, long-lasting immunity in poultry. By exposing birds to controlled levels of the parasite, vaccination stimulates the immune system without causing severe disease. This approach is particularly valuable in addressing drug resistance challenges and supporting “antibiotic-free” production systems.

Nutritional strategies and feed additives

Beyond traditional methods, innovative nutritional strategies and the inclusion of specific feed additives are gaining prominence in coccidiosis management. These approaches often focus on supporting gut health, enhancing the bird’s natural immune response, and creating an environment less conducive to parasite proliferation. Natural compounds, such as certain botanicals, probiotics, and prebiotics, are being explored for their potential to reduce oocyst shedding, improve intestinal barrier function, and modulate the gut microbiome to benefit the host.

See all feed additives for poultry

Vetagro solutions: supporting poultry health from within

At Vetagro, we understand the intricate interplay between nutrition, gut health, and disease resistance. Our commitment to scientific research and innovative microencapsulation technology allows us to develop targeted feed additive solutions that support poultry health and performance, even in the face of persistent challenges like coccidiosis.

One such example is AviPower®2, a unique blend of selected botanicals microencapsulated in a lipid matrix. This innovative formulation ensures the active ingredients bypass the acidic gastric environment and are slowly released along the entire intestinal tract, where their action is most needed. AviPower®2 is designed to support the live performance of poultry in the presence of coccidia by:

• Improving feed efficiency.
• Restoring gut integrity and reducing intestinal lesions.
• Interfering with the Eimeria life cycle through the multi-functional properties of its botanical components.

AviPower®2 is compatible with conventional drug and vaccination programs, offering a valuable tool for integrated coccidiosis management strategies. Our research demonstrates that microencapsulation maximizes the efficacy of these compounds, even at lower concentrations, contributing to more sustainable and efficient poultry production.